SkyCell

PharmaLifeScience News

...

Samsung Biologics and European pharma company enter major manufacturing deal
The global CDMO has entered into several high-value manufacturing deals this year.
READ MORE
...

Pharma giant Janssen seeking to expand Ringaskiddy manufacturing site
The Ringaskiddy facility been in operation since 2005 and currently employs around 700 people
READ MORE
...

Europe’s TCR immunotherapy licensing deals surge 123% above US in 2024
TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.
READ MORE

Zai Lab and Pfizer to commercialise XACDURO in China

Sustainability in biopharma: Collaboration and technology light the way forward

EMA accepts Alvotech and Advanz Pharma’s Marketing Authorization Application for biosimilar of J&J’s Simponi

Aditum Bio and Leads Biolabs join forces in new company to fight autoimmune diseases

Enveda raises $130m to advance AI-driven plant based drug development

Synaffix and BigHat Biosciences collaborate to develop AI-designed ADC

Anocca submits Clinical Trial Application

USC and Autobahn Labs team up to advance breakthrough drug research

Freya Biosciences secures new investment to develop microbial immunotherapies for bacterial vaginosis

Hovione to create 20 new jobs with pharma investment in Cork

GSK eyes up combo approval for previously withdrawn myeloma drug

ProductLife Group (PLG) Acquires Halloran

Novartis acquires Kate Therapeutics to advance gene therapies

Novartis and Ratio enter radiotherapeutics partnership worth $745m

The future of media hydration: balanced media in automated single-use platforms

MAS-100 Libra®: the future of continuous cleanroom monitoring

Versant startup sets out to make a new type of obesity drug

Amgen and Pfizer appoint new Science executives

AI-designed drug ISM5939 granted IND clearance for cancer clinical trials

BridgeBio poised to challenge Pfizer after Attruby approval

Adcendo raises $135m as ADC funding frenzy continues
Ellab